UNSPSC 51143215: Nicotine dihydrochloride

This classification denotes a nicotinic agonist and alkaloid with the molecular formula C10H14N2.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I16I55623S, chemically known as nicotine dihydrochloride, (-)-, but more generally known as nicotine dihydrochloride, which bears US NIH Compound Identifier 80115. European Medicines Agency schedules nicotine dihydrochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14645MIG.

Most nations, for tariff purposes, schedule nicotine dihydrochloride under HS 29399990. SMILES: CN1CCC[C@H]1C2CCCNC2.CL.CL.

UNSPSC 51143215 Nicotine dihydrochloride is a Commodity code with minimal recent state and local procurement activity aligned to its nominal scope. The two recent opportunities tagged to this code procure naloxone and drug deactivation systems (Seminole County, Florida) and pharmaceutical direct-to-manufacturer prescription programs (Texas Health and Human Services Commission), neither of which involves nicotine dihydrochloride as a product or service. The mismatch between the code's chemical designation and the actual goods being solicited suggests the code sees little relevant activity in state and local contracting right now, or the tagged opportunities reflect misclassification in the posting systems.

Seminole County's IFB60459723LAS, posted June 30, 2026, with response due July 26, 2023, seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; vendors must include shipping and delivery costs and hold workers' compensation, commercial general liability, and professional liability insurance. Texas HHS Commission's RFI HHS0017013, posted April 3, 2026, gathers vendor capabilities on direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and group purchasing organization channels, targeting self-insured employers and government health plans. Neither opportunity is germane to nicotine dihydrochloride procurement. If your firm pursues chemical or pharmaceutical commodity sales to state and local health agencies, this code warrants review for tagging accuracy before bidding; current activity does not support focused effort under this specific commodity designation.